Swiss All Share Index
17.244,71
PKT
+48,68
PKT
+0,28
%
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 19.12.12 | UBS buy | Vontobel Research | |
| 18.12.12 | Holcim buy | Banc of America Securities-Merrill Lynch | |
| 18.12.12 | Holcim overweight | J.P. Morgan Cazenove | |
| 18.12.12 | Holcim neutral | Banc of America Securities-Merrill Lynch | |
| 18.12.12 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
| 18.12.12 | Holcim neutral | Sarasin Research | |
| 18.12.12 | Holcim hold | Vontobel Research | |
| 17.12.12 | Holcim neutral | Citigroup Corp. | |
| 17.12.12 | Holcim buy | Citigroup Corp. | |
| 17.12.12 | Lonza hold | Vontobel Research | |
| 17.12.12 | Zurich Insurance hold | Vontobel Research | |
| 17.12.12 | Zurich Insurance neutral | Sarasin Research | |
| 17.12.12 | Holcim hold | Vontobel Research | |
| 14.12.12 | Partners Group kaufen | Sarasin Research | |
| 14.12.12 | ABB (Asea Brown Boveri) sell | Deutsche Bank AG | |
| 14.12.12 | Baloise hold | Vontobel Research | |
| 14.12.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 14.12.12 | Zurich Insurance outperform | Sanford C. Bernstein and Co., Inc. | |
| 13.12.12 | Novartis hold | Deutsche Bank AG | |
| 13.12.12 | Sika neutral | Sarasin Research | |
| 13.12.12 | Barry Callebaut reduce | Sarasin Research | |
| 13.12.12 | Sika hold | Vontobel Research | |
| 13.12.12 | Barry Callebaut hold | Vontobel Research | |
| 12.12.12 | Swatch (I) buy | Nomura | |
| 12.12.12 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 12.12.12 | Novartis outperform | Credit Suisse Group | |
| 12.12.12 | Barry Callebaut neutral | Sarasin Research | |
| 11.12.12 | Tecan (N) buy | UBS AG | |
| 11.12.12 | Swiss Life buy | Sarasin Research | |
| 11.12.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 11.12.12 | UBS outperform | Exane-BNP Paribas SA | |
| 11.12.12 | Adecco SA buy | Deutsche Bank AG | |
| 11.12.12 | Novartis halten | Norddeutsche Landesbank (Nord/LB) | |
| 11.12.12 | Avolta (ex Dufry) buy | Vontobel Research | |
| 11.12.12 | Novartis reduce | Vontobel Research | |
| 10.12.12 | UBS neutral | Exane-BNP Paribas SA | |
| 10.12.12 | Straumann kaufen | Die Actien-Börse | |
| 10.12.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 10.12.12 | Baloise buy | Nomura | |
| 10.12.12 | ARYZTA neutral | Sarasin Research |